-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: BIO
USPTO to Issue Proposal for “Track One” Accelerated Patent Examination in Flexible “Three Track” Patent Processing Program
In case you missed this last week, the USPTO will be issuing a Federal Register Notice requesting comments on their proposed Track One Accelerated Patent Examination requirements. The forthcoming Federal Register notice will request comments from the public on a number of different proposed requirements for participation in Track One, including (a) the proposed fee of $4,000 for each application (to recover the full cost of resources necessary to prevent the delay of other, non-prioritized applications); Read More >
BIO Commends Senate Judiciary Committee Passage of Patent Reform Act of 2011
BIO Commends Senate Judiciary Committee Passage of Patent Reform Act of 2011 Bipartisan, consensus-oriented approach will strengthen nation’s patent system Washington, D.C. (February 3, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the passage today of The Patent Reform Act of 2011 (S. 23) by the Senate Judiciary Committee: “BIO commends the Senate Judiciary Committee for passing The Patent Reform Act of 2011. We appreciate the Read More >
BIO’s Intellectual Property Counsels’ Committee Spring Conference and Meeting: Seattle
Over the past eight years, BIO’s semiannual IP Counsels Committee Conference has become a popular and growing event among our members’ IP and legal professionals. Our upcoming 2011 Spring IPCC Conference in Seattle, WA on April 13-15 will be an excellent opportunity for IP professionals to hear, listen, and learn about current and projected topics related to biotechnology IP. We invite you to join us in an informal, fun and informative setting to meet fellow in-house Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: BIO, biosimilars, biotechnology, Biotechnology Industry Organization, double patenting, emerging markets, Ethics for In-House IP Attorneys, Intellectual Property, Intellectual Property Counsels' Committee, IP Counsels' Committee, IPCC, Myriad, Seattle, Stanford v. Roche
Tags: BIO, biosimilars, biotechnology, Biotechnology Industry Organization, double patenting, emerging markets, Ethics for In-House IP Attorneys, Intellectual Property, Intellectual Property Counsels' Committee, IP Counsels' Committee, IPCC, Myriad, Seattle, Stanford v. Roche
Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review
We are receiving reports from Brazil that the Brazilian Attorney General of the Union (AGU) has adopted a position restricting the role of the National Agency for Sanitary Surveillance (ANVISA) in the patenting process for pharmaceutical products and processes. Due to a lack of clarity in the Industrial Property Law, ANVISA has used its prior consent role to reject patent applications on the basis of novelty and inventiveness which is officially the role of the Read More >
BIO Press Release: Former British Prime Minister Tony Blair to Present a Keynote Address at 2011 BIO International Convention
Former British Prime Minister Tony Blair to Present a Keynote Address at 2011 BIO International Convention Convention to take place June 27-30, 2011 in Washington, DC WASHINGTON, D.C. – (January 31, 2011) – The Biotechnology Industry Organization (BIO) announced today that former British Prime Minister Tony Blair will participate in a keynote presentation at the 2011 BIO International Convention. BIO President and CEO Jim Greenwood will host an “Interview with Tony Blair” during Read More >
